Skip to content
The mifepristone saga is entering its next chapter. On August 16, 2023, the U.S. Court of Appeals for the Fifth Court for the Northern […]
Appeals court rules to restrict access to mifepristone Read More »
Childhood vaccination rates get a lot of attention, but it’s equally important to work on adult vaccination rates, too. “Right now, as a number
National Immunization Awareness Month: A conversation with GSK on adult vaccine access Read More »
Merck on July 27 announced positive Phase 3 results for a new pneumococcal conjugate vaccine, which targets several varieties of bacteria that cause pneumococcal pneumonia.
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial Read More »
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with
With the deadly threat of drug-resistant infections increasing daily, we desperately need actions to address the broken commercial marketplace for novel antimicrobials—including the PASTEUR
Legislation to fight AMR superbugs is an urgent need, BIO member tells Senate hearing Read More »
The Senate Health, Education, Labor, and Pensions (HELP) Committee released a bipartisan discussion draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bill
Senate HELP’s PAHPA draft: The good, the bad, and the ugly Read More »
During the 2023 BIO International Convention, the Biotechnology Innovation Organization (BIO) released its seventh-annual best practices report, “The U.S. Biosciences Industry in the States:
How can states grow their biosciences sectors? Read More »
Healthcare on the African continent is changing. “At the current pace, the annual rate of cancer in Africa is projected to reach 1.4 million
How do we achieve the cancer moonshot in Africa? Read More »
Psychedelics have established themselves as a game changer in the drug development space in recent years. And it is not just scientists who are
Psychedelics ‘do things in the brain that nothing else does’ Read More »
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation
How can we increase routine adult vaccination? Read More »
